A recent review in Pharmacological Reviews highlights that over the last decade, a renaissance has occurred in psychedelic drug research in North America and Europe as investigators at Johns Hopkins School of Medicine, University of California, Los Angeles (UCLA), New York University and Imperial College London have embarked on studies that could be paradigm-changing for psychiatry (Nichols, 2016). These developments overturn a 30-year embargo on psychedelic research that followed political reactions to the 1960s counter-culture movement in the United
States and elsewhere, as disgraced Harvard Professor Timothy Leary told the world to take psychedelics to ‘turn on, tune in and drop out’. Promising research was halted, not for lack of theoretical interest and clinical applications but due to political pressure (Nutt et al., 2013).
Read the full journal here. https://drive.google.com/file/d/14LTqvg9fFACjgCj2x4JCehKgyLpSxk1K/view?usp=sharing
Image By Sharm Murugiah
